Wellness Franchise Opportunities

PartnershipApr, 24 2015

Pharma major Zydus collaborates with US-based NIAD research centre to develop vaccine

Leading Zydus Pharmaceuticals have collaborated its R&D subsidiary Etna Biotech with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL) or Kala-Azar in India.

By Agencies

Pharmaceuticals major Zydus recently announced that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in India.

Etna Biotech will also donate $2,40,000 for advancing research under the NIH leishmaniasis programme.

Reportedly, Zydus disclosed the collaboration news in a BSE filing, and noted, "Under a separate agreement, Etna Biotech also extended its support of the NIH leishmaniasis programme by donating $2,40,000 for research.”

Zydus Cadila, a global pharmaceutical company that discovers, manufactures and markets a broad range of healthcare therapies, is headquartered in Ahmedabad city of Gujarat.

Meanwhile, Pankaj R Patel, Chairman and Managing Director of Zydus Group told mediapersons, "Zydus is proud to collaborate with US NIH to solve the increasing worldwide disease burden of visceral leishmaniasis and to move forward to put a basis for the successful development of a novel candidate vaccine for visceral leishmaniasis."

The Zydus Group employs over 16,500 people worldwide, including over 1,600 scientists, who are involved in R&D for the company. Cadila Healthcare is a part of Zydus Group.
 

Related: IBM launches health unit; teams up with Apple, Johnson&Johnson and Medtronic

Click Here to add Comment
Please add your Comment
Rating
Sell Business 2017
Sell Franchise 2017

Newsletter Signup

Submit your email address to receive the latest updates on news & host of opportunities from Wellness India.

Video

Magazines & Books

Read the latest franchising magazines and books to get comprehensive and up-to-date information on leading franchise systems, trends and more.


Newsletter Signup
Submit your email address to receive the latest updates on news & host of opportunities.
Well Ness India

Copyright © 2009 - 2017 Franchise India Holdings Ltd.

The information contained herein is of generic nature only, and Franchise India is not, by means of this website or any part thereof, rendering professional advice or services. Before making any decision or taking any action that might affect your finances or business, you should consult a qualified professional advisor. Your use of this website or any of its pages or links given, is at your own risk and you assume full responsibility and risk of loss resulting from your usage. With respect to use of the website, kindly visit www.franchiseindia.com/terms.